Table S7.
Variables considered | EFS | |||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
EGFL7 risk group, favorable vs. unfavorable | 0.48 (0.31–0.77) | 0.002 | 0.44 (0.28–0.70) | <0.001 | 0.46 (0.29–0.72) | <0.001 |
WBC count, continuous | 1.22 (1.05–1.40) | 0.007 | 1.20 (1.04–1.39) | 0.01 | 1.17 (1.01–1.36) | 0.04 |
miR-155, high vs. low* | 1.68 (1.14–2.47) | 0.008 | — | — | — | — |
Platelets, continuous | — | — | 1.16 (1.04–1.28) | 0.006 | — | — |
Extramedullary involvement, present vs. absent | — | — | — | — | 1.63 (1.05–2.53) | 0.03 |
HRs greater than (or less than) 1.0 indicate higher (or lower) failure to achieve complete remission, relapse, or death (EFS) for the higher value of the continuous variables and the first category listed for the categorical variables.
The median expression value was used as the cut point.